Devic's neuromyelitis optica: A case with mitochondrial DNA mutations [1]

European Neurology

Volumn 55, Issue 2, 2006, Pages 93-95

  Çelebisoy, Neşe ^a   Akyurekli, Onder ^a   Copur, Asli ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; MITOCHONDRIAL DNA;

ADULT; CASE REPORT; FEMALE; GENE MUTATION; HUMAN; LETTER; LIMB WEAKNESS; MOTOR DYSFUNCTION; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL; SPINAL CORD ATROPHY; URINARY DYSFUNCTION; VISUAL IMPAIRMENT;

ADULT; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; FEMALE; GENETIC SCREENING; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MYELITIS; NEUROLOGIC EXAMINATION; NEUROMYELITIS OPTICA; OPTIC ATROPHY; OPTIC NERVE; SPINAL CORD;

EID: 33646803834     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092781     Document Type: Letter

References (26)

1. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG: The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107-1114.
2. Pambakian A, Akdal G, Kennard C: Neuromyelitis optica (Devic's disease) and its relationship to MS. Int Mult Scler 2000;6:91-95.
3. Weinshenker BG: Neuromyelitis optica: what it is and what it might be. Lancet 2003;361:889-890.
4. Bergamaschi R, Ghezzi A: Devic's neuromyelitis optica: clinical features and prognostic factors. Neurol Sci 2004;25:S364-S367.
5. Filippi M, Rocca MA: MR imaging of Devic's neuromyelitis optica. Neurol Sci 2004;25:S371-S373.
6. Zaffaroni M, the Italian Devic's Study Group: Cerebrospinal fluid findings in Devic's neuromyelitis optica. Neurol Sci 2004;25:S368-S370.
7. Fazekas F, Offenbacher H, Schmidt R, Strasser-Fuchs S: MRI of neuromyelitis optica. Evidence for a distinct entity. J Neurol Neurosurg Psychiatry 1994;57:1140-1142.
8. Wingerchuk DM, Weinshenker BG: Neuromyelitis optica. Clinical predictors of a relapsing course and survival. Neurology 2003;60:848-853.
9. Bergamaschi R, Ghezzi A: Devic's neuromyelitis optica: clinical features and prognostic factors. Neurol Sci 2004;25:S364-S367.
10. Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E, Mancardi L, Gallo P, Filippi M, Zaffaroni M, Comi G and the Italian Devic's Study Group: Clinical characteristics, course and prognosis of relapsing Devic's neuromyelitis optica. J Neurol 2004;251:47-52.
11. Mandler RN, Davis LE, Jeffery DR, Kornfeld M: Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 1993;34:162-168.
12. Giorgi D, Balacco Gabriel C, Bonomo L: The association of optic neuropathy with transverse myelitis with systemic lupus erythamatosus. Rheumatology 1999;32:191-192.
13. Tesar JT, Mc Millan V, Molina R, Armstrong J: Optic neuropathy and central nervous system disease associated with Sjögren's syndrome. Am J Med 1992;92:686-692.
14. Ghezzi A, Baldini S, Zaffaroni M, Leoni G, Koudriavtseva T, Casini AR, Zeviani M: Devic's neuromyelitis optica and mitochondrial DNA mutation: a case report. Neurol Sci 2004; 25:S380-S382.
15. Harding AE, Sweeney MG, Miller DH, Mumford CJ, Kellar-Wood H, Menard D, McDonald WI, Compston DAS: Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992;115:979-989.
16. Flanigan KM, Johns DR: Association of the 11778 mitochondrial DNA mutation and demyelinating disease. Neurology 1993;3:2720-2722.
17. Kellar-Wood H, Robertson N, Govan GG, Compston DAS, Harding AE: Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol 1994;36:109-112.
18. Carrara F, Eoli M, La Mantina L, Zeviani M: The contribution of LHON mitochondrial DNA muations to multiple sclerosis. Am J Hum Genet 1995;57:A336.
19. Leuzzi V, Carducci C, Lanza M. Salvetti M, Ristori G, Di Giovanni S, Torroni A: LHON mutations in Italian patients affected by multiple sclerosis. Acta Neurol Scand 1997;96:145-148.
20. Vanopdenbosch L, Dubois B, D'Hooghe MB, Meire F, Carton H: Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis. J Neurol 2000;247:535-543.
21. Chalmers RM, Robertson N, Compston DAS, Harding AE: Sequence of mitochondrial DNA in patients with multiple sclerosis. Ann Neurol 1996;40:239-243.
22. Kalman B, Lublin FD, Adler H: Characterization of the mitochondrial DNA in patients with multiple sclerosis. J Neurol Sci 1996;140:75-89.
23. Franciotta D, Bergamaschi R, Piccolo G, Zardini E, Cosi V: Multiple secondary Leber's hereditary optic neuropathy mutations in Italian patients with multiple sclerosis. J Neurol 2000;247:304-305.
24. Hwang JM, Chang BL, Park SS: Leber's hereditary optic neuropathy mutations in Korean patients with multiple sclerosis. Ophthalmology 2001;215:398-400.
25. Penisson-Besnier I, Moreau C, Jacques C, Roger JC, Dubas F, Revnier P: Multiple sclerosis and Leber's hereditary optic neuropathy mitochondrial DNA mutations. Rev Neurol 2001;157:537-541.
26. Torroni A, Petrozzi M, D'Urbano L, Sellitto D, Zeviani M, Carrara F, Carducci C, Leuzzi V, Carelli V, Barboni P, De Negri A, Scozzari R: Haplotype and phylogenetic analysis suggest that one European-specific mtDNA background plays a role in the expression of the primary mutations 11778 and 14484. Am J Hum Genet 1997;60:1107-1121.